Forskning ved Københavns Universitet - Københavns Universitet

Forside

Discovery, characterization, and clinical development of the glucagon-like peptides

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Dokumenter

The discovery, characterization, and clinical development of glucagon-like-peptide-1 (GLP-1) spans more than 30 years and includes contributions from multiple investigators, science recognized by the 2017 Harrington Award Prize for Innovation in Medicine. Herein, we provide perspectives on the historical events and key experimental findings establishing the biology of GLP-1 as an insulin-stimulating glucoregulatory hormone. Important attributes of GLP-1 action and enteroendocrine science are reviewed, with emphasis on mechanistic advances and clinical proof-of-concept studies. The discovery that GLP-2 promotes mucosal growth in the intestine is described, and key findings from both preclinical studies and the GLP-2 clinical development program for short bowel syndrome (SBS) are reviewed. Finally, we summarize recent progress in GLP biology, highlighting emerging concepts and scientific insights with translational relevance.

OriginalsprogEngelsk
TidsskriftThe Journal of Clinical Investigation
Vol/bind127
Udgave nummer12
Sider (fra-til)4217-4227
Antal sider11
ISSN0021-9738
DOI
StatusUdgivet - 1 dec. 2017

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 189623179